Immunotherapy for NSCLC: Recent advances and future directions

Bookmark and Share
Published: 27 Jan 2020
Views: 688
Prof Neal Ready - Duke University School of Medicine, Durham, USA

Prof Neal Ready speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the different immunotherapies available to treat non-small-cell lung cancer (NSCLC).

He describes the recent advances in this area, including the selection of patients, based on their PDL-1 expression for example.

Prof Ready highlights the different types of therapy available for these patients and describes what the future looks like in this field.